Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients
Status:
Completed
Trial end date:
2011-09-24
Target enrollment:
Participant gender:
Summary
This is an open-label, multi-center, two-part, parallel-design study to assess the PK,
safety, and tolerability of TR-701 FA and its active metabolite, TR-700, following a single
oral dose (Part A) or IV dose (Part B) of TR-701 FA in 12 to 17 year old adolescent patients.